FR2871696B1 - Composition topique pour le traitement du psoriasis - Google Patents
Composition topique pour le traitement du psoriasisInfo
- Publication number
- FR2871696B1 FR2871696B1 FR0406613A FR0406613A FR2871696B1 FR 2871696 B1 FR2871696 B1 FR 2871696B1 FR 0406613 A FR0406613 A FR 0406613A FR 0406613 A FR0406613 A FR 0406613A FR 2871696 B1 FR2871696 B1 FR 2871696B1
- Authority
- FR
- France
- Prior art keywords
- psoriasis
- treatment
- topical composition
- topical
- composition
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Expired - Fee Related
Links
- 201000004681 Psoriasis Diseases 0.000 title 1
- 230000000699 topical effect Effects 0.000 title 1
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/56—Compounds containing cyclopenta[a]hydrophenanthrene ring systems; Derivatives thereof, e.g. steroids
- A61K31/57—Compounds containing cyclopenta[a]hydrophenanthrene ring systems; Derivatives thereof, e.g. steroids substituted in position 17 beta by a chain of two carbon atoms, e.g. pregnane or progesterone
- A61K31/573—Compounds containing cyclopenta[a]hydrophenanthrene ring systems; Derivatives thereof, e.g. steroids substituted in position 17 beta by a chain of two carbon atoms, e.g. pregnane or progesterone substituted in position 21, e.g. cortisone, dexamethasone, prednisone or aldosterone
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/59—Compounds containing 9, 10- seco- cyclopenta[a]hydrophenanthrene ring systems
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/0012—Galenical forms characterised by the site of application
- A61K9/0014—Skin, i.e. galenical aspects of topical compositions
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/10—Dispersions; Emulsions
- A61K9/12—Aerosols; Foams
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/10—Dispersions; Emulsions
- A61K9/12—Aerosols; Foams
- A61K9/122—Foams; Dry foams
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P17/00—Drugs for dermatological disorders
- A61P17/06—Antipsoriatics
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
- A61K47/06—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite
- A61K47/08—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite containing oxygen, e.g. ethers, acetals, ketones, quinones, aldehydes, peroxides
- A61K47/14—Esters of carboxylic acids, e.g. fatty acid monoglycerides, medium-chain triglycerides, parabens or PEG fatty acid esters
Landscapes
- Health & Medical Sciences (AREA)
- Chemical & Material Sciences (AREA)
- Public Health (AREA)
- Veterinary Medicine (AREA)
- Medicinal Chemistry (AREA)
- Pharmacology & Pharmacy (AREA)
- Life Sciences & Earth Sciences (AREA)
- Animal Behavior & Ethology (AREA)
- General Health & Medical Sciences (AREA)
- Epidemiology (AREA)
- Dispersion Chemistry (AREA)
- Dermatology (AREA)
- Engineering & Computer Science (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Chemical Kinetics & Catalysis (AREA)
- General Chemical & Material Sciences (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Organic Chemistry (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Medicinal Preparation (AREA)
Priority Applications (12)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
FR0406613A FR2871696B1 (fr) | 2004-06-17 | 2004-06-17 | Composition topique pour le traitement du psoriasis |
US10/965,195 US20050281755A1 (en) | 2004-06-17 | 2004-10-15 | Topical foam/mousse compositions for treating psoriasis |
RU2007101540/15A RU2007101540A (ru) | 2004-06-17 | 2005-06-15 | Пенообразная композиция под давлением для топического лечения псориаза |
CA002567687A CA2567687A1 (fr) | 2004-06-17 | 2005-06-15 | Composition moussante pressurisee pour le traitement topique du psoriasis |
CNA2005800199993A CN1968681A (zh) | 2004-06-17 | 2005-06-15 | 用于局部给药治疗牛皮癣的加压泡沫组合物 |
JP2007515998A JP2008502663A (ja) | 2004-06-17 | 2005-06-15 | 乾癬の局所治療用加圧型発泡性組成物 |
PCT/FR2005/001496 WO2006005844A1 (fr) | 2004-06-17 | 2005-06-15 | Composition moussante pressurisee pour le traitement topique du psoriasis |
AU2005261571A AU2005261571A1 (en) | 2004-06-17 | 2005-06-15 | Pressurized foaming composition for topical treatment of psoriasis |
KR1020067026292A KR20070024598A (ko) | 2004-06-17 | 2005-06-15 | 건선의 국소 치료용 가압화 발포성 조성물 |
EP05777132A EP1778185A1 (fr) | 2004-06-17 | 2005-06-15 | Composition moussante pressurisée pour le traitement topique du psoriasis |
BRPI0510840-3A BRPI0510840A (pt) | 2004-06-17 | 2005-06-15 | composição farmacêutica, composição pressurizada, bomba aerossol e uso de uma mistura de análogo de vitamina d e de um corticosteróide |
MXPA06014409A MXPA06014409A (es) | 2004-06-17 | 2005-06-15 | Composicion de espuma presurizada para tratamiento topico de psoriasis. |
Applications Claiming Priority (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
FR0406613A FR2871696B1 (fr) | 2004-06-17 | 2004-06-17 | Composition topique pour le traitement du psoriasis |
Publications (2)
Publication Number | Publication Date |
---|---|
FR2871696A1 FR2871696A1 (fr) | 2005-12-23 |
FR2871696B1 true FR2871696B1 (fr) | 2006-11-10 |
Family
ID=34949090
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
FR0406613A Expired - Fee Related FR2871696B1 (fr) | 2004-06-17 | 2004-06-17 | Composition topique pour le traitement du psoriasis |
Country Status (12)
Country | Link |
---|---|
US (1) | US20050281755A1 (fr) |
EP (1) | EP1778185A1 (fr) |
JP (1) | JP2008502663A (fr) |
KR (1) | KR20070024598A (fr) |
CN (1) | CN1968681A (fr) |
AU (1) | AU2005261571A1 (fr) |
BR (1) | BRPI0510840A (fr) |
CA (1) | CA2567687A1 (fr) |
FR (1) | FR2871696B1 (fr) |
MX (1) | MXPA06014409A (fr) |
RU (1) | RU2007101540A (fr) |
WO (1) | WO2006005844A1 (fr) |
Families Citing this family (60)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
AUPP583198A0 (en) * | 1998-09-11 | 1998-10-01 | Soltec Research Pty Ltd | Mousse composition |
US8263580B2 (en) * | 1998-09-11 | 2012-09-11 | Stiefel Research Australia Pty Ltd | Vitamin formulation |
US8512718B2 (en) | 2000-07-03 | 2013-08-20 | Foamix Ltd. | Pharmaceutical composition for topical application |
IL152486A0 (en) | 2002-10-25 | 2003-05-29 | Meir Eini | Alcohol-free cosmetic and pharmaceutical foam carrier |
US20060018937A1 (en) * | 2002-10-25 | 2006-01-26 | Foamix Ltd. | Steroid kit and foamable composition and uses thereof |
US8486376B2 (en) | 2002-10-25 | 2013-07-16 | Foamix Ltd. | Moisturizing foam containing lanolin |
CA2502986C (fr) | 2002-10-25 | 2011-08-23 | Foamix Ltd. | Mousse cosmetique et pharmaceutique |
US9668972B2 (en) | 2002-10-25 | 2017-06-06 | Foamix Pharmaceuticals Ltd. | Nonsteroidal immunomodulating kit and composition and uses thereof |
US10117812B2 (en) | 2002-10-25 | 2018-11-06 | Foamix Pharmaceuticals Ltd. | Foamable composition combining a polar solvent and a hydrophobic carrier |
US9211259B2 (en) | 2002-11-29 | 2015-12-15 | Foamix Pharmaceuticals Ltd. | Antibiotic kit and composition and uses thereof |
US7704518B2 (en) | 2003-08-04 | 2010-04-27 | Foamix, Ltd. | Foamable vehicle and pharmaceutical compositions thereof |
US7820145B2 (en) | 2003-08-04 | 2010-10-26 | Foamix Ltd. | Oleaginous pharmaceutical and cosmetic foam |
US20080138296A1 (en) | 2002-10-25 | 2008-06-12 | Foamix Ltd. | Foam prepared from nanoemulsions and uses |
US8119109B2 (en) | 2002-10-25 | 2012-02-21 | Foamix Ltd. | Foamable compositions, kits and methods for hyperhidrosis |
US7700076B2 (en) | 2002-10-25 | 2010-04-20 | Foamix, Ltd. | Penetrating pharmaceutical foam |
US8900554B2 (en) | 2002-10-25 | 2014-12-02 | Foamix Pharmaceuticals Ltd. | Foamable composition and uses thereof |
US8119150B2 (en) | 2002-10-25 | 2012-02-21 | Foamix Ltd. | Non-flammable insecticide composition and uses thereof |
US9265725B2 (en) | 2002-10-25 | 2016-02-23 | Foamix Pharmaceuticals Ltd. | Dicarboxylic acid foamable vehicle and pharmaceutical compositions thereof |
US7575739B2 (en) | 2003-04-28 | 2009-08-18 | Foamix Ltd. | Foamable iodine composition |
US8486374B2 (en) | 2003-08-04 | 2013-07-16 | Foamix Ltd. | Hydrophilic, non-aqueous pharmaceutical carriers and compositions and uses |
US8795693B2 (en) | 2003-08-04 | 2014-08-05 | Foamix Ltd. | Compositions with modulating agents |
US8211449B2 (en) * | 2004-06-24 | 2012-07-03 | Dpt Laboratories, Ltd. | Pharmaceutically elegant, topical anhydrous aerosol foam |
BRPI0612428A2 (pt) | 2005-05-09 | 2010-11-09 | Foamix Ltd | composição farmacêutica higroscópica, veìculo farmacêutico espumoso e composição farmacêutica espumosa |
ES2407407T3 (es) | 2005-06-01 | 2013-06-12 | Glaxosmithkline Intellectual Property Development Limited | Formulación de vitamina |
CN101505725A (zh) * | 2006-08-29 | 2009-08-12 | 特瓦制药工业有限公司 | 包含含维生素D的化合物和皮质类固醇化合物的具有低pH相容性的稳定的药理学活性组合物 |
GB2443162B (en) * | 2006-10-28 | 2011-02-09 | Nupharm Lab Ltd | Betamethasone spray |
GB2443161B (en) * | 2006-10-28 | 2011-03-23 | Nupharm Lab Ltd | Clobetasol spray |
US20080260655A1 (en) | 2006-11-14 | 2008-10-23 | Dov Tamarkin | Substantially non-aqueous foamable petrolatum based pharmaceutical and cosmetic compositions and their uses |
US9532936B2 (en) * | 2007-03-08 | 2017-01-03 | Strength Of Nature, Llc | Compositions and methods for removing hair styling aids |
US10265265B2 (en) | 2007-03-15 | 2019-04-23 | Drug Delivery Solutions Limited | Topical composition |
EP1970048A1 (fr) * | 2007-03-15 | 2008-09-17 | Drug Delivery Solutions Limited | Composition topique de type polyaphron avec de la vitamine D |
EP1970049A1 (fr) * | 2007-03-15 | 2008-09-17 | Drug Delivery Solutions Limited | Composition topique du type polyaphron avec de la vitamine D et un corticosteroide |
FR2915097B1 (fr) * | 2007-04-18 | 2012-09-28 | Fabre Pierre Dermo Cosmetique | Mousse antifongique a base de ciclopiroxolamine et de pyrithione de zinc et ses applications medicales et cosmetiques. |
EP2008651A1 (fr) | 2007-06-26 | 2008-12-31 | Drug Delivery Solutions Limited | Patch bioérodable |
US8636982B2 (en) | 2007-08-07 | 2014-01-28 | Foamix Ltd. | Wax foamable vehicle and pharmaceutical compositions thereof |
WO2009069006A2 (fr) | 2007-11-30 | 2009-06-04 | Foamix Ltd. | Peroxyde de benzoyle contenant de la mousse |
US8518376B2 (en) | 2007-12-07 | 2013-08-27 | Foamix Ltd. | Oil-based foamable carriers and formulations |
WO2009090495A2 (fr) | 2007-12-07 | 2009-07-23 | Foamix Ltd. | Vecteurs moussants siliconés à base d'huile et de liquide, et formulations |
AU2009205314A1 (en) | 2008-01-14 | 2009-07-23 | Foamix Ltd. | Poloxamer foamable pharmaceutical compositions with active agents and/or therapeutic cells and uses |
KR20110067145A (ko) * | 2008-10-03 | 2011-06-21 | 넥스메드 홀딩스 인코포레이티드 | 건선 치료용 안정화된 조성물 |
US20120238535A1 (en) * | 2009-02-23 | 2012-09-20 | Smith Jan G | Topical formulation of low level clobetasol propionate for treating disorders of the skin and mucous membranes |
PT2400951T (pt) * | 2009-02-25 | 2018-11-26 | Mayne Pharma Llc | Composições de espuma tópica |
CA2760186C (fr) | 2009-04-28 | 2019-10-29 | Foamix Ltd. | Vehicule moussant et compositions pharmaceutiques comportant des solvants polaires aprotiques et leurs utilisations |
WO2011013009A2 (fr) | 2009-07-29 | 2011-02-03 | Foamix Ltd. | Compositions hydro-alcooliques moussantes non tensioactives, mousses légères, et leurs utilisations |
CA2769677A1 (fr) | 2009-07-29 | 2011-02-03 | Foamix Ltd. | Compositions hydro-alcooliques moussantes a base d'agents non tensioactifs non polymeres, mousses legeres, et leurs utilisations |
CA2776366C (fr) | 2009-10-02 | 2017-07-18 | Foamix Ltd. | Compositions moussantes sans eau et sans surfactant, mousses et gels friables, ainsi que leurs utilisations |
US9849142B2 (en) | 2009-10-02 | 2017-12-26 | Foamix Pharmaceuticals Ltd. | Methods for accelerated return of skin integrity and for the treatment of impetigo |
CN102939078B (zh) | 2010-06-11 | 2014-12-24 | 利奥制药有限公司 | 含有维生素d类似物和皮质类固醇的药用喷雾剂组合物 |
AU2015203836B2 (en) * | 2010-06-11 | 2016-09-01 | Leo Pharma A/S | A pharmaceutical spray composition comprising a vitamin d analogue and a corticosteroid |
ES2736256T3 (es) | 2011-03-14 | 2019-12-27 | Drug Delivery Solutions Ltd | Composición oftálmica |
US20150376161A1 (en) | 2013-01-29 | 2015-12-31 | Avexxin As | Antiiflammatory and antitumor 2-oxothiazoles abd 2-oxothiophenes compounds |
JP6396229B2 (ja) * | 2014-01-27 | 2018-09-26 | 株式会社ポーラファルマ | 使用時泡状を呈する外用医薬組成物 |
JP6396230B2 (ja) * | 2014-01-27 | 2018-09-26 | 株式会社ポーラファルマ | 使用時泡状を呈する外用医薬組成物 |
GB201413695D0 (en) | 2014-08-01 | 2014-09-17 | Avexxin As | Compound |
FR3041538B1 (fr) * | 2015-09-29 | 2018-11-30 | Galderma Research & Development | Mousse chimique non rincee contenant du propionate de clobetasol, et son utilisation dans le traitement du psoriasis. |
GB201604316D0 (en) | 2016-03-14 | 2016-04-27 | Avexxin As | Combination therapy |
GB201604318D0 (en) | 2016-03-14 | 2016-04-27 | Avexxin As | Combination therapy |
MX2017011630A (es) | 2016-09-08 | 2018-09-25 | Foamix Pharmaceuticals Ltd | Composiciones y metodos para tratar rosacea y acne. |
EP3515422A1 (fr) | 2016-09-21 | 2019-07-31 | Avexxin AS | Composition pharmaceutique |
EP3542788A1 (fr) | 2018-03-19 | 2019-09-25 | MC2 Therapeutics Limited | Composition topique comprenant calcipotriol et dipropionate de bétaméthasone |
Family Cites Families (18)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US3949098A (en) * | 1974-06-05 | 1976-04-06 | Nabisco, Inc. | Nutritious orange drink concentrate, process and drink resultant therefrom |
US4610978A (en) * | 1983-03-22 | 1986-09-09 | Yissum Research Development Company Of The Hebrew University Of Jerusalem | Compositions containing 1α-hydroxycholecalciferol for topical treatment of skin disorders and methods employing same |
US5223244A (en) * | 1988-06-20 | 1993-06-29 | Shiseido Company, Ltd. | Aerosol composition |
US5185166A (en) * | 1988-12-07 | 1993-02-09 | San-Ei Chemical Industries, Ltd. | Process for the production of milk mineral concentrate and drink containing minerals |
US5158761A (en) * | 1989-04-05 | 1992-10-27 | Toko Yakuhin Kogyo Kabushiki Kaisha | Spray gel base and spray gel preparation using thereof |
GB9004544D0 (en) * | 1990-03-01 | 1990-04-25 | Leo Pharm Prod Ltd | Novel treatment ii |
US5087620A (en) * | 1990-05-17 | 1992-02-11 | Bristol-Myers Squibb Co. | Controlled dermal penetration enhancement using imidazoles |
USRE39706E1 (en) * | 1993-01-15 | 2007-06-26 | Leo Pharma A/S | Crystalline form of a vitamin D analogue |
FR2701396B1 (fr) * | 1993-02-12 | 1995-04-21 | Oreal | Procédé de stabilisation de vésicules de lipide(s) amphiphile(s) et composition pour application topique contenant lesdites vésicules stabilisées. |
FR2740038B1 (fr) * | 1995-10-20 | 1998-01-02 | Lafon Labor | Composition pour l'administration transdermique |
US6126949A (en) * | 1998-04-06 | 2000-10-03 | Bernel Chemical Company, Inc. | Di-behenyl fumarate and its use in dermatological products |
US6106874A (en) * | 1998-11-18 | 2000-08-22 | Abbott Laboratories | Calcium fortified juice-based nutritional supplement and process of making |
ES2671785T3 (es) * | 1999-04-23 | 2018-06-08 | Leo Pharma A/S | Composición farmacéutica para uso dérmico para el tratamiento de la psoriasis que comprende vitamina D y un corticosteroide |
US7074747B1 (en) * | 1999-07-01 | 2006-07-11 | Johnson & Johnson Consumer Companies, Inc. | Cleansing compositions |
AU9163701A (en) * | 2000-10-27 | 2002-05-06 | Leo Pharma As | Topical composition containing at least one vitamin D or one vitamin D analogue and at least one corticosteroid |
US20030059446A1 (en) * | 2001-09-18 | 2003-03-27 | Kulkarni Arun B. | Physically stable sprayable gel composition |
FR2848454B1 (fr) * | 2002-12-17 | 2007-03-30 | Galderma Res & Dev | Composition pharmaceutique comprenant une association de calcitriol et d'un corticosteroide |
AU2003294027B2 (en) * | 2002-12-17 | 2009-09-10 | Galderma S.A. | Pharmaceutical compositions comprising a combination of calcitriol and a clobetasol propionate |
-
2004
- 2004-06-17 FR FR0406613A patent/FR2871696B1/fr not_active Expired - Fee Related
- 2004-10-15 US US10/965,195 patent/US20050281755A1/en not_active Abandoned
-
2005
- 2005-06-15 WO PCT/FR2005/001496 patent/WO2006005844A1/fr active Application Filing
- 2005-06-15 JP JP2007515998A patent/JP2008502663A/ja not_active Withdrawn
- 2005-06-15 CA CA002567687A patent/CA2567687A1/fr not_active Abandoned
- 2005-06-15 KR KR1020067026292A patent/KR20070024598A/ko not_active Application Discontinuation
- 2005-06-15 MX MXPA06014409A patent/MXPA06014409A/es not_active Application Discontinuation
- 2005-06-15 BR BRPI0510840-3A patent/BRPI0510840A/pt not_active Application Discontinuation
- 2005-06-15 CN CNA2005800199993A patent/CN1968681A/zh active Pending
- 2005-06-15 AU AU2005261571A patent/AU2005261571A1/en not_active Abandoned
- 2005-06-15 EP EP05777132A patent/EP1778185A1/fr not_active Withdrawn
- 2005-06-15 RU RU2007101540/15A patent/RU2007101540A/ru unknown
Also Published As
Publication number | Publication date |
---|---|
EP1778185A1 (fr) | 2007-05-02 |
WO2006005844A1 (fr) | 2006-01-19 |
FR2871696A1 (fr) | 2005-12-23 |
JP2008502663A (ja) | 2008-01-31 |
CA2567687A1 (fr) | 2006-01-19 |
US20050281755A1 (en) | 2005-12-22 |
KR20070024598A (ko) | 2007-03-02 |
BRPI0510840A (pt) | 2007-11-27 |
RU2007101540A (ru) | 2008-07-27 |
CN1968681A (zh) | 2007-05-23 |
MXPA06014409A (es) | 2007-02-19 |
AU2005261571A1 (en) | 2006-01-19 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
FR2871696B1 (fr) | Composition topique pour le traitement du psoriasis | |
DE602005014621D1 (de) | 3-ä4-heterocyclyl-1,2,3-triazol-1-ylü-n-arylbenzamide als inhibitoren der cytokinenproduktion für die behandlung von chronischen entzündlichen erkrankungen | |
MA29098B1 (fr) | Compositions pour le traitement du vhc | |
FR2915102B1 (fr) | Utilisation d'un anticorps anti-cxcr4 pour le traitement du cancer | |
ITMI20020756A1 (it) | Composizioni farmaceutiche topiche per il trattamento delle dermatiti | |
ATE478864T1 (de) | Hydantoinderivate zur behandlung von entzündlichen erkrankungen | |
ATE434620T1 (de) | Dihydrothienopyrimidine zur behandlung von entzündlichen erkrankungen | |
FR13C0029I2 (fr) | Compositions pour le traitement de troubles gastro-intestinaux | |
DE602005007717D1 (de) | Imidazolverbindungen zur behandlung von neurodegenerativen erkrankungen | |
FR2887141B1 (fr) | Orthese compressive tricotee du membre inferieur pour le traitement de l'insuffisance veineuse chronique | |
GB2445674B (en) | Compositions for the topical treatment of eczema, psoriasis and the like | |
FR2907011B1 (fr) | Utilisation de la citrulline pour le traitement des etats de denutrition | |
PT2056814E (pt) | Compostos de 2,5-di-hidroxibenzeno para o tratamento da psoríase | |
FR2897533B1 (fr) | Agent oxydant pour le traitement des cheveux | |
FR2893501B1 (fr) | Compositions topiques pour favoriser l'homeostasie de la peau | |
DE602006006950D1 (de) | Zusammensetzungen, Verwendungen und Kit für die Behandlung von Dermatitis | |
DE602004026081D1 (de) | Therapeutische humanisierte antikörper gegen cd45-isoformen | |
FR2906468B1 (fr) | Utilisation de composes de la famille des avermectines pour le traitement de desordres dermatologiques | |
FR2860154B1 (fr) | Composition pour le traitement de la mauvaise haleine | |
FR2917947B1 (fr) | Composition phytosanitaire pour le traitement preventif et curatif du mildiou | |
DK1503747T3 (da) | Diclofenacbaseret sammensætning til topisk behandling af sygdomme | |
FR2865403B1 (fr) | Composition pour le traitement d'une pathologie associee a la msrv/herv-w | |
FR2905600B1 (fr) | Traitement des vertiges par l'acetyl-l-leucine. | |
FR2887456B1 (fr) | "composition pour le traitement de la dermite estivale" | |
FR2908995B1 (fr) | Utilisation de l'agomelatine pour l'obtention de medicaments destines au traitement du syndrome de smith magenis |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
ST | Notification of lapse |
Effective date: 20090228 |